Reversal of the effects of new oral anticoagulants by treatment with FEIBA

被引:0
|
作者
Schiviz, Alexandra [1 ]
Schrenk, Gerald [1 ]
Dietrich, Barbara [1 ]
Turecek, Peter L. [1 ]
Scheiflinger, Friedrich [1 ]
Muchitsch, Eva-Maria [1 ]
Hoellrieg, Werner [1 ]
机构
[1] Baxter Innovat GmbH, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:82 / 82
页数:1
相关论文
共 50 条
  • [1] Reversal of the effects of new oral anticoagulants by administration of FEIBA
    Schiviz, A.
    Verdino, D.
    Schrenk, G.
    Resch, M.
    Neyens, I
    Dietrich, B.
    Turecek, P. L.
    Scheiflinger, F.
    Muchitsch, E. M.
    Hoellriegl, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 366 - 366
  • [2] New Oral Anticoagulants and Their Reversal
    Pinto, Ian
    Giri, Anshu
    Arshad, Umbreen
    Gajra, Ajeet
    CURRENT DRUG SAFETY, 2015, 10 (03) : 208 - 216
  • [3] Reversal of New Oral Anticoagulants
    Battinelli, Elisabeth M.
    CIRCULATION, 2011, 124 (14) : 1508 - 1510
  • [4] New oral anticoagulants and their reversal agents
    Laslo, Crista L.
    Stoian, Anca Pantea
    Socea, Bogdan
    Paduraru, Dan N.
    Bodean, Oana
    Socea, Laura I.
    Neagu, Tiberiu Paul
    Stanescu, Ana Maria Alexandra
    Marcu, Drags
    Diaconu, Camelia C.
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2018, 5 (02): : 195 - 201
  • [5] New Oral Anticoagulants and Their Reversal Agents
    Andrea Morotti
    Joshua N. Goldstein
    Current Treatment Options in Neurology, 2016, 18
  • [6] New Oral Anticoagulants and Their Reversal Agents
    Morotti, Andrea
    Goldstein, Joshua N.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (11)
  • [7] Thrombin generation assay to monitor the reversal of anticoagulants by FEIBA
    Turecek, P. L.
    Schrenk, G.
    Schaedler, M.
    Peyrer-Heimstaett, S.
    Rottensteiner, H.
    Scheiflinger, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 956 - 956
  • [8] Reversal of new oral anticoagulants and personalized medicine
    Iqbal, Omer
    Jeske, Walter
    Fareed, Jawed
    PERSONALIZED MEDICINE, 2017, 14 (01) : 5 - 7
  • [9] Monitoring and reversal strategies for new oral anticoagulants
    Vanden Daelen, Sophie
    Peetermans, Marijke
    Vanassche, Thomas
    Verhamme, Peter
    Vandermeulen, Erik
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (01) : 95 - 103
  • [10] New Reversal Agents for Oral Anticoagulants on the Horizon
    Mazur, Marcus D.
    Sivakumar, Walavan
    Taussky, Philipp
    Park, Min S.
    WORLD NEUROSURGERY, 2015, 84 (06) : 1506 - 1507